|
TMEM128 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.19950000000169E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.05020000004974E-06 |
| Normal-vs-Stage2 |
2.458000E-02 |
| Normal-vs-Stage3 |
1.219400E-03 |
| Normal-vs-Stage4 |
1.526630E-01 |
| Stage1-vs-Stage2 |
2.735000E-01 |
| Stage1-vs-Stage3 |
9.803200E-01 |
| Stage1-vs-Stage4 |
2.581400E-01 |
| Stage2-vs-Stage3 |
4.045600E-01 |
| Stage2-vs-Stage4 |
8.066800E-01 |
| Stage3-vs-Stage4 |
3.842000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.228700E-04 |
| Normal-vs-AfricanAmerican |
1.614440E-04 |
| Normal-vs-Asian |
8.619500E-03 |
| Caucasian-vs-AfricanAmerican |
2.515800E-01 |
| Caucasian-vs-Asian |
3.738800E-01 |
| AfricanAmerican-vs-Asian |
6.625800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.96420000000109E-05 |
| Normal-vs-Female |
9.88149999999743E-05 |
| Male-vs-Female |
6.182800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.211100E-04 |
| Normal-vs-Extreme_Weight |
4.375200E-04 |
| Normal-vs-Obese |
5.048200E-04 |
| Normal-vs-Extreme_Obese |
7.883900E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.162200E-01 |
| Normal_Weight-vs-Obese |
9.719400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.883600E-01 |
| Extreme_Weight-vs-Obese |
9.386600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.454800E-01 |
| Obese-vs-Extreme_Obese |
8.065800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.810650E-04 |
| Normal-vs-Age(41-60Yrs) |
5.611400E-04 |
| Normal-vs-Age(61-80Yrs) |
9.56149999999933E-05 |
| Normal-vs-Age(81-100Yrs) |
1.808390E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.074100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.294600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.601200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.188400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.234000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.014200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.807250E-04 |
| Normal-VS-Type2 PRCC |
8.20500000000557E-05 |
| Normal-VS-KIRP CIMP |
2.53340000000435E-06 |
| Normal-VS-Unclassified PRCC |
6.583600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.652800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.516800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.751000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.170300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.923770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.403300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33719999995119E-06 |
| Normal-vs-N1 |
3.147700E-02 |
| Normal-vs-N2 |
1.565590E-01 |
| N0-vs-N1 |
5.673600E-01 |
| N0-vs-N2 |
4.761000E-01 |
| N1-vs-N2 |
8.945200E-01 |
|
|
